Renee  is one of the most experienced and well respected generic pharmaceutical industry professionals.

After graduating from Hofstra University with a degree in International Marketing,  Renee began her pharmaceutical career  just as the Hatch-Waxman Act established the generic industry as we know it today.   Renee worked for MWM Chemical Company and Globe Chemicals, both trading companies interested in tapping the potential of this new market, and she successfully established each company’s position in the US generic market by offering API’s from overseas suppliers.  As the industry quickly evolved, Renee recognized that both customers and suppliers alike wanted the more knowledgeable and service oriented approach of a commercial agent rather than a trader.  Accordingly, in 1990 Renee created Ren-Pharm International, Ltd. with a boutique focus, choosing to represent only a limited number of the highest quality global suppliers  which shared her same principles of service, follow-up, and dedication to the customer. 

While the Company has grown and evolved over the year,  it remains deeply rooted in the founding principles which gives Ren-Pharm International, Ltd. the designation as one of the most respected companies in the generic industry today.

With over 20 years of experience in pharmaceutical, Mariana brings extensive technical expertise to her role as Technical Director at Ren-Pharm. She joined the company in 2013 and has played a key role in supporting clients and API manufacturing partners throughout the R&D and commercial lifecycle of projects.

Mariana oversees projects from both commercial and technical perspectives, with particular expertise in analytical matters. Serving as a key liaison between API suppliers and clients, she facilitates effective communication, coordinates technical requirements, and helps ensure projects progress efficiently and successfully.

Prior to joining Ren-Pharm, Mariana held R&D and technical positions at Interpharm, Luitpold Pharmaceuticals, and Endo Pharmaceuticals, where she gained experience in analytical chemistry, pharmaceutical R&D, and technical procurement. Her earlier career also included laboratory experience in food and blood testing.

Mariana holds a B.C. in Chemistry from Babeș-Bolyai University in Cluj-Napoca, Romania, and an M.S. in Chemistry from Long Island University in New York.

With over 30 years of global experience and a Doctorate in Chemistry and Pharmaceutical Technologies from the University of Milan, Dr. Barbara Galbiati is a highly respected pharmaceutical quality, regulatory, and CMC leader. She brings a unique combination of business, technical, quality, regulatory, and operational expertise across both API and drug product development and manufacturing.
Having held global leadership positions with prominent organizations—including Boehringer Ingelheim/Roxane, Curia (AMRI), and Veranova (Johnson Matthey Health)—Barbara has managed hundreds of global regulatory submissions, directed R&D and quality organizations across numerous manufacturing sites, and led complex, cross-functional projects throughout the product lifecycle. Her experience includes technology transfer, CMC strategy and execution, and quality operations, and the oversight of complex activities involving internal teams, CDMOs, and external suppliers.
Today, Barbara provides strategic and hands-on support to pharmaceutical companies navigating complex CMC, quality, regulatory, and manufacturing challenges. She serves as a CMC expert and trusted liaison between clients and CDMOs and suppliers—helping teams effectively assess technical and quality issues, align expectations, resolve challenges, and keep complex projects moving forward. Her ability to bridge technical, business, quality, and regulatory perspectives makes her a flexible extension of leadership teams and a valuable partner in both strategic initiatives and high-stakes operational situations.

Robyn brings a high-impact background in business development, API supplier selection, and finished drug products to the leadership team at RJW Pharma.

Her career includes valuable experience at Ren-Pharm International and a standout four-and-a-half-year tenure at Lannett Company. During her time at Lannett, she established herself as a skilled dealmaker, successfully executing over 40 commercial agreements and leading R&D API sourcing initiatives.

At RJW Pharma, Robyn utilizes her deep understanding of both raw active ingredients and final drug products to connect global entities and build powerful, strategic alliances.

Robyn holds a bachelor’s degree in Business Administration from the University of Vermont.